These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19221687)

  • 41. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.
    Alberts MJ; Bhatt DL; Mas JL; Ohman EM; Hirsch AT; Röther J; Salette G; Goto S; Smith SC; Liau CS; Wilson PW; Steg PG;
    Eur Heart J; 2009 Oct; 30(19):2318-26. PubMed ID: 19720633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-year cardiovascular event rates in outpatients with atherothrombosis.
    Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
    JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
    Schuler J; Maier B; Behrens S; Thimme W
    Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].
    Suárez C; Castillo J; Esmatjes E; Sala J; Cairols M; Montoto C; Barberá G;
    Med Clin (Barc); 2009 Apr; 132(14):537-44. PubMed ID: 19393390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome.
    Morillas P; Quiles J; Cordero A; Guindo J; Soria F; Mazón P; Gonzalez-Juanatey JR; Bertomeu V;
    Am J Cardiol; 2009 Dec; 104(11):1494-8. PubMed ID: 19932781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.
    Darmon A; Elbez Y; Bhatt DL; Abtan J; Mas JL; Cacoub P; Montalescot G; Billaut-Laden I; Ducrocq G; Steg PG
    Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):158-166. PubMed ID: 32778388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction.
    Hirsch AT; Gotto AM
    Vasc Med; 2002; 7(4):323-31. PubMed ID: 12710848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
    Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
    Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study.
    Kohro T; Hayashi D; Okada Y; Yamazaki T; Nagai R;
    Circ J; 2007 Dec; 71(12):1835-40. PubMed ID: 18037732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study.
    Si S; Golledge J; Norman P; Nelson M; Chew D; Ademi Z; Bhatt DL; Steg GP; Reid CM
    Heart Lung Circ; 2019 Jun; 28(6):939-945. PubMed ID: 29843973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry.
    Yeo TC; Chan YH; Low LP; Venketasubramanian N; Lim SC; Tay JC; Tan RS; Eng P; Lingamanaicker J;
    Ann Acad Med Singap; 2008 May; 37(5):365-71. PubMed ID: 18536821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins and biomarkers in claudicants with peripheral arterial disease: cross-sectional study.
    DePalma RG; Hayes VW; May PE; Cafferata HT; Mohammadpour HA; Brigg LA; Chow BK; Shamayeva G; Zacharski LR
    Vascular; 2006; 14(4):193-200. PubMed ID: 17026909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Missed opportunities for the secondary prevention of cardiovascular disease in Canada.
    Hackam DG; Leiter LA; Yan AT; Yan RT; Mendelsohn A; Tan M; Zavodni L; Chen R; Tsang JL; Kundi A; Lin PJ; Fitchett DH; Langer A; Goodman SG;
    Can J Cardiol; 2007 Dec; 23(14):1124-30. PubMed ID: 18060097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Office management of peripheral arterial disease.
    Aronow WS
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.